Chomei; Nobuo
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chomei; Nobuo.The latest application filed is for "isoxazole derivative and isothiazole derivative having inhibitory activity on 11(beta)-hydroxysteroid dehydrogenase type i".
- Chomei; Nobuo - Osaka JP
- Chomei; Nobuo - Sakai JP
| Patent | Date |
|---|---|
| Isoxazole derivative and isothiazole derivative having inhibitory activity on 11.beta.-hydroxysteroid dehydrogenase type 1 Grant 8,017,638 - Ogawa , et al. September 13, 2 | 2011-09-13 |
| ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11(beta)-HYDROXYSTEROID DEHYDROGENASE TYPE I App 20090131491 - Ogawa; Tomoyuki ; et al. | 2009-05-21 |
| Isoxazole derivatives as peroxisome proliferator-activated receptors agonists App 20070054902 - Fukui; Yoshikazu ; et al. | 2007-03-08 |
| Condensed imidazopyridine derivatives Grant 5,461,062 - Takada , et al. October 24, 1 | 1995-10-24 |
| Condensed imidazopyridine derivatives Grant 5,378,848 - Takada , et al. January 3, 1 | 1995-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 